| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/16/2009 | US20090181995 2-anilino-4-aminoalkyleneaminopyrimidines |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
| 07/16/2009 | US20090181970 Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181942 Tricyclic compounds |
| 07/16/2009 | US20090181929 Organic compounds |
| 07/16/2009 | US20090181899 Low-molecular weight peptides inhibiting ion channel activity |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181095 Oxidative stress inhibitor |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090180998 Methods of isolating non-senescent cardiac stem cells and uses thereof |
| 07/16/2009 | US20090180957 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 07/16/2009 | DE10301300B4 Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein Use of acylated 4-amidino and 4-Guanidinobenzylaminen for the inhibition of plasma kallikrein |
| 07/16/2009 | CA2711834A1 Synthetic triterpenoids and methods of use in the treatment of disease |
| 07/16/2009 | CA2711815A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/16/2009 | CA2711803A1 Pyridine derivatives |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | CA2711179A1 Rna interference for the treatment of heart failure |
| 07/16/2009 | CA2711160A1 Pterin analog for treating bh4 responsive condition |
| 07/15/2009 | EP2078719A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 07/15/2009 | EP2078022A1 Spiro benzazepines used as vasopressin antagonists |
| 07/15/2009 | EP2078012A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 07/15/2009 | EP2077999A1 Hydroxamates as inhibitors of histone deacetylase |
| 07/15/2009 | EP2077993A1 Method for the separation of s-(-)-amlodipine from racemic amlodipine |
| 07/15/2009 | EP2077728A2 Use of nutritional compositions for preventing disorders |
| 07/15/2009 | EP1874329B1 Blood pressure lowering protein hydrolysates |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512849C Use of extracted total timosaponin for producing myocardial ischemia treating products |
| 07/15/2009 | CN100512825C Icy seven drop pills and its preparation method |
| 07/15/2009 | CN100512812C Method of extracting red indigo peucin and red indigo peucin cinnamic ester from Korean Angelica |
| 07/15/2009 | CN100512810C Premixed amiodarone parenteral solution and method for making the same |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560586 Acid and ester compounds and methods of using the same |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560532 Smad6 and uses thereof |
| 07/14/2009 | US7560487 In particular, kidneys |
| 07/14/2009 | US7560486 An isotonic lipid emulsion free of vegetable oils:(i) 78 to 95% by weight of medium chain triglycerides (MCT), (ii) 5 to 22% by weight of fish oil; to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues |
| 07/14/2009 | US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560461 Quinazoline derivatives as kinase inhibitors |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | CA2521133C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha.-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/14/2009 | CA2439222C Identification of partial agonists of the a2a adenosine receptor |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/14/2009 | CA2379841C Biphenyl derivatives, the preparation thereof and their use as medicaments |
| 07/14/2009 | CA2360776C Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders |
| 07/09/2009 | WO2009086429A1 Soluble epoxide hydrolase inhibitors |
| 07/09/2009 | WO2009086426A2 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
| 07/09/2009 | WO2009086166A1 Room temperature stable, lyophilized natriuretic peptide formulations |
| 07/09/2009 | WO2009086130A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | WO2009086123A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | WO2009085475A1 Method for detection and treatment of aneurysms |
| 07/09/2009 | WO2009084970A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084678A1 Oral cavity disintegrating tablet and method of producing the same |
| 07/09/2009 | WO2009084653A1 Method for screening of cell-protecting agent |
| 07/09/2009 | WO2009084531A1 Monosebacate of pyrazole derivative |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009084040A1 Once a day formulation of angiotensin receptor blockers |
| 07/09/2009 | WO2009083739A1 Method of synthesis of bosentan, its polymorphic forms and its salts |
| 07/09/2009 | WO2009083177A1 TREATMENT OF HEART DISEASE USING β-BLOCKERS |
| 07/09/2009 | WO2009043524A3 Use of a peptide as therapeutic agent |
| 07/09/2009 | WO2009033814A3 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 07/09/2009 | WO2009033806A3 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/09/2009 | WO2009033764A3 Use of a peptide as a therapeutic agent |
| 07/09/2009 | WO2009033749A3 Use of thymopentin as a therapeutic agent |
| 07/09/2009 | WO2009033748A3 Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent |
| 07/09/2009 | WO2009008991A3 Dna-pkcs modulates energy regulation and brain function |
| 07/09/2009 | WO2008147864A3 Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| 07/09/2009 | WO2008040002A3 Methods, compositions and articles of manufacture for hif modulating compounds |
| 07/09/2009 | WO2008039087A8 Indoline derivatives and uses thereof |
| 07/09/2009 | WO2008000186A8 A method for identifying novel gene and the resulting novel genes |
| 07/09/2009 | US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 07/09/2009 | US20090176889 Compounds for the treatment of metabolic disorders |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176879 Fatty acid desaturases from primula |
| 07/09/2009 | US20090176874 Tnp-470 polymer conjugates and use thereof |
| 07/09/2009 | US20090176863 Thiophene derivative ppar modulators |
| 07/09/2009 | US20090176860 Zofenopril calcium |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176848 Fortifier |
| 07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |